With just a few days remaining in July, the FDA has approved four novel drugs this month, including a treatment for a parasitic “sleeping sickness” and a drug proven to significantly slow the progression of chronic kidney disease. This brings the total number of novel drug approvals by the FDA so far this year to 31. For a look at the biotech stocks facing FDA decisions in August – and their respective product candidates – CLICK HERE.
Will August Bring FDA Approvals For These Biotech Stocks?
